Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.64%
0%
12.64%
6 Months
2.49%
0%
2.49%
1 Year
3.86%
0%
3.86%
2 Years
-16.58%
0%
-16.58%
3 Years
22.26%
0%
22.26%
4 Years
-23.96%
0%
-23.96%
5 Years
-17.89%
0%
-17.89%
Tri Chemical Laboratories Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
21.22%
EBIT Growth (5y)
20.76%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.48
Tax Ratio
25.13%
Dividend Payout Ratio
22.92%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.25%
ROE (avg)
16.41%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
2.83
EV to EBIT
12.99
EV to EBITDA
10.57
EV to Capital Employed
3.34
EV to Sales
3.69
PEG Ratio
0.12
Dividend Yield
NA
ROCE (Latest)
25.69%
ROE (Latest)
17.11%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ
Apr'25
Jan'25
Change(%)
Net Sales
6,569.90
5,800.60
13.26%
Operating Profit (PBDIT) excl Other Income
2,120.70
2,106.30
0.68%
Interest
6.20
6.00
3.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,207.60
1,735.50
-30.42%
Operating Profit Margin (Excl OI)
260.70%
302.30%
-4.16%
USD in Million.
Net Sales
QoQ Growth in quarter ended Apr 2025 is 13.26% vs 13.05% in Jan 2025
Consolidated Net Profit
QoQ Growth in quarter ended Apr 2025 is -30.42% vs 45.21% in Jan 2025
Annual Results Snapshot (Consolidated) - Jan'25
Jan'25
Jan'24
Change(%)
Net Sales
18,905.90
11,246.30
68.11%
Operating Profit (PBDIT) excl Other Income
6,628.90
3,252.60
103.80%
Interest
23.70
23.70
Exceptional Items
0.00
0.00
Consolidate Net Profit
4,962.00
2,470.60
100.84%
Operating Profit Margin (Excl OI)
278.00%
173.20%
10.48%
USD in Million.
Net Sales
YoY Growth in year ended Jan 2025 is 68.11% vs -18.53% in Jan 2024
Consolidated Net Profit
YoY Growth in year ended Jan 2025 is 100.84% vs -48.87% in Jan 2024
About Tri Chemical Laboratories Inc. 
Tri Chemical Laboratories Inc.
Diversified
No Details Available.
Company Coordinates 
No Company Details Available






